Investigation of sensitization mechanisms and recombinant allergen-based diagnosis for American cockroach allergy

碩士 === 國立彰化師範大學 === 生物技術研究所 === 97 === Cockroaches are known to produce potent aeroallergens which elicit IgE-mediated allergy and strongly associated with asthma. Traditional methods of cockroach allergy diagnosis and treatment are based on the use of crude extracts containing wide variety of undes...

Full description

Bibliographic Details
Main Authors: Szu-Wei Liu, 劉思偉
Other Authors: Nancy M. Wang
Format: Others
Language:zh-TW
Published: 2009
Online Access:http://ndltd.ncl.edu.tw/handle/78943930853478440489
id ndltd-TW-097NCUE5108013
record_format oai_dc
spelling ndltd-TW-097NCUE51080132015-10-13T12:05:45Z http://ndltd.ncl.edu.tw/handle/78943930853478440489 Investigation of sensitization mechanisms and recombinant allergen-based diagnosis for American cockroach allergy 探討美國蟑螂的致敏機轉及美國蟑螂重組過敏原應用於檢測蟑螂過敏病 Szu-Wei Liu 劉思偉 碩士 國立彰化師範大學 生物技術研究所 97 Cockroaches are known to produce potent aeroallergens which elicit IgE-mediated allergy and strongly associated with asthma. Traditional methods of cockroach allergy diagnosis and treatment are based on the use of crude extracts containing wide variety of undesirable protein, which leaves rooms for improvability regarding the test sensitivity and specificity. In the Part I of this study, we would like to utilize recombinant proteins (rPer a 1.0104, 3.0203 and 7.0101) to replace cockroach crude extracts in clinical diagnosis and immunotherapy. A total of 118 sera from cockroach-allergic patients were collected and analyzed for their specific IgE against rPer a 1.0104, 3.0203 and 7..0101 IgE ELISA results showed that the prevalence of IgE antibodies to rPer a 1.0104, 3.0203 and 7.0101 were 66.1%, 67.8% and 57.6%, respectively. Current data demonstrated that Per a 1.0104, 3.0203 and 7.0101are important P. americana major allergens that should be considered for clinical use. The use of component-resolved diagnostics may be useful to evaluate the allergen cocktails for immunotherapy by monitoring patient’s IgE directed to relevant allergens. Beside, the mechanisms underlying epithelial cell activation by American cockroach allergens (Cra A) are unclear. Interleukin (IL) -8 plays a critical role in the persistence of the inflammatory process in allergy. In the Part II, we aimed to investigate the mechanism by which Cra A triggers IL-8 released from human airway epithelial cells. Firstly, we determined the effects of Cra A on IL-8 expression and secretion in A549 cells. Cra A stimulated the production of IL-8 at protein and mRNA levels with dose- and time-dependent manners. Secondly, the effect of Cra A on IL-8 release was blocked by serine-protease inhibitors, PMSF and aprotinin; while it could not be suppressed by cysteine- or aspartic protease inhibitors. It demonstrated that serine protease activities were found in the extract of American cockroach. Thirdly, A549 cells expressed all four protease-activated receptors (PARs) at mRNA levels as assessed by real-time PCR. When epithelial cells were stimulated with Cra A, PAR-2 and PAR-3 mRNAs reached up to 1.73 and 1.94-folds increase than nonstimulated cells. Finally, we investigated the role of mitogen-activated protein kinases (MAPK) from PAR-2 or PAR-3 activation in IL-8 synthesis. Western blotting showed that an increase in ERK1/2 and JNK phosphorylation after Cra A stimulation. Furthermore, when A549 cells were preincubated with U0126 (ERK 1/2 kinase inhibitor) or SP600125 (JNK kinase inhibitor), it resulted in a reduction 100% and 44% of IL-8 production, respectively. We conclude that Cra A induced IL-8 release in airway epithelial cells and this is dependent on activation of PAR-2 and-3, and coordinating with the ERK1/2 and JNK signaling pathways. Nancy M. Wang Mey-Fann Lee 王妙媛 李美芳 2009 學位論文 ; thesis 68 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立彰化師範大學 === 生物技術研究所 === 97 === Cockroaches are known to produce potent aeroallergens which elicit IgE-mediated allergy and strongly associated with asthma. Traditional methods of cockroach allergy diagnosis and treatment are based on the use of crude extracts containing wide variety of undesirable protein, which leaves rooms for improvability regarding the test sensitivity and specificity. In the Part I of this study, we would like to utilize recombinant proteins (rPer a 1.0104, 3.0203 and 7.0101) to replace cockroach crude extracts in clinical diagnosis and immunotherapy. A total of 118 sera from cockroach-allergic patients were collected and analyzed for their specific IgE against rPer a 1.0104, 3.0203 and 7..0101 IgE ELISA results showed that the prevalence of IgE antibodies to rPer a 1.0104, 3.0203 and 7.0101 were 66.1%, 67.8% and 57.6%, respectively. Current data demonstrated that Per a 1.0104, 3.0203 and 7.0101are important P. americana major allergens that should be considered for clinical use. The use of component-resolved diagnostics may be useful to evaluate the allergen cocktails for immunotherapy by monitoring patient’s IgE directed to relevant allergens. Beside, the mechanisms underlying epithelial cell activation by American cockroach allergens (Cra A) are unclear. Interleukin (IL) -8 plays a critical role in the persistence of the inflammatory process in allergy. In the Part II, we aimed to investigate the mechanism by which Cra A triggers IL-8 released from human airway epithelial cells. Firstly, we determined the effects of Cra A on IL-8 expression and secretion in A549 cells. Cra A stimulated the production of IL-8 at protein and mRNA levels with dose- and time-dependent manners. Secondly, the effect of Cra A on IL-8 release was blocked by serine-protease inhibitors, PMSF and aprotinin; while it could not be suppressed by cysteine- or aspartic protease inhibitors. It demonstrated that serine protease activities were found in the extract of American cockroach. Thirdly, A549 cells expressed all four protease-activated receptors (PARs) at mRNA levels as assessed by real-time PCR. When epithelial cells were stimulated with Cra A, PAR-2 and PAR-3 mRNAs reached up to 1.73 and 1.94-folds increase than nonstimulated cells. Finally, we investigated the role of mitogen-activated protein kinases (MAPK) from PAR-2 or PAR-3 activation in IL-8 synthesis. Western blotting showed that an increase in ERK1/2 and JNK phosphorylation after Cra A stimulation. Furthermore, when A549 cells were preincubated with U0126 (ERK 1/2 kinase inhibitor) or SP600125 (JNK kinase inhibitor), it resulted in a reduction 100% and 44% of IL-8 production, respectively. We conclude that Cra A induced IL-8 release in airway epithelial cells and this is dependent on activation of PAR-2 and-3, and coordinating with the ERK1/2 and JNK signaling pathways.
author2 Nancy M. Wang
author_facet Nancy M. Wang
Szu-Wei Liu
劉思偉
author Szu-Wei Liu
劉思偉
spellingShingle Szu-Wei Liu
劉思偉
Investigation of sensitization mechanisms and recombinant allergen-based diagnosis for American cockroach allergy
author_sort Szu-Wei Liu
title Investigation of sensitization mechanisms and recombinant allergen-based diagnosis for American cockroach allergy
title_short Investigation of sensitization mechanisms and recombinant allergen-based diagnosis for American cockroach allergy
title_full Investigation of sensitization mechanisms and recombinant allergen-based diagnosis for American cockroach allergy
title_fullStr Investigation of sensitization mechanisms and recombinant allergen-based diagnosis for American cockroach allergy
title_full_unstemmed Investigation of sensitization mechanisms and recombinant allergen-based diagnosis for American cockroach allergy
title_sort investigation of sensitization mechanisms and recombinant allergen-based diagnosis for american cockroach allergy
publishDate 2009
url http://ndltd.ncl.edu.tw/handle/78943930853478440489
work_keys_str_mv AT szuweiliu investigationofsensitizationmechanismsandrecombinantallergenbaseddiagnosisforamericancockroachallergy
AT liúsīwěi investigationofsensitizationmechanismsandrecombinantallergenbaseddiagnosisforamericancockroachallergy
AT szuweiliu tàntǎoměiguózhānglángdezhìmǐnjīzhuǎnjíměiguózhānglángzhòngzǔguòmǐnyuányīngyòngyújiǎncèzhānglángguòmǐnbìng
AT liúsīwěi tàntǎoměiguózhānglángdezhìmǐnjīzhuǎnjíměiguózhānglángzhòngzǔguòmǐnyuányīngyòngyújiǎncèzhānglángguòmǐnbìng
_version_ 1716853239223156736